- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | As COVID demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50% | ||
| Do | Not just AstraZeneca: Hackers targeted 5 other COVID drug developers, vaccine cold chain suppliers | ||
| Do | Anthony Fauci slams U.K.'s speedy review of Pfizer, BioNTech COVID shot | ||
| Do | How can the $23B market for PD-1 blockers grow? 'Pan-adjuvant' use is key: report | ||
| Do | Biohaven revs up migraine med Nurtec ODT with NASCAR sponsorship | ||
| Do | JSR's CDMO arm plans $150M biologics facility in Research Triangle alongside unnamed pharma partner | ||
| Do | Pharma payments to physicians still deliver a big 'return on investment' in prescription growth, study finds | ||
| Mi | Roche, Blueprint catches up with Lilly as Gavreto snags FDA thyroid cancer nod | ||
| Mi | CDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology market | ||
| Mi | Merck spotlights cancer survivorship in first podcast series featuring patients and loved ones | ||
| Mi | Lonza plots 2 manufacturing suites for antibody-drug conjugates at Switzerland site | ||
| Mi | Merck cashes in on Moderna COVID-19 vaccine enthusiasm with sale of equity stake | ||
| Mi | The $38B pie: Pfizer, Moderna COVID-19 vaccines set for lion's share of 2021 sales | ||
| Mi | Pfizer, BioNTech nabs COVID vaccine authorization from UK for first-ever marketed mRNA shot | ||
| Di | Halozyme scores $190M Horizon deal to develop subQ Tepezza formula | ||
| Di | Why isn't Pfizer's COVID vaccine OK'd yet? White House calls in FDA chief Hahn to explain: Axios | ||
| Di | Amgen, Takeda and UCB join forces in new COVID-19 drug repurposing study | ||
| Di | Indivior faces lawsuit from ex-parent company RB over Suboxone marketing scheme | ||
| Di | FDA goes beyond the label to educate doctors-and enlighten others-about new cancer drugs | ||
| Di | AstraZeneca hands European Crestor rights to old customer Grünenthal for $350M | ||
| Mo | AstraZeneca staffers targeted in suspected hacking scheme amid work on COVID vaccine: report | ||
| Mo | Revance's frown-line injection latest to face regulatory delay after FDA can't hit inspection deadline | ||
| Mo | McKinsey consultants proposed Purdue offer rebates for opioid overdoses: NYT | ||
| Mo | Boehringer Ingelheim features Queen Latifah, Bernie Williams in new lung disease documentary | ||
| Mo | Signed, sealed, delivered: Pfizer marks 1st 'mass air shipment' of COVID-19 shot amid cold-chain scrutiny |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
